Uflex (500148) Q3 24/25 earnings summary
Event summary combining transcript, slides, and related documents.
Q3 24/25 earnings summary
21 Nov, 2025Executive summary
Q3 FY25 revenue grew 12.8% year-over-year to INR 3,774 crores (Rs. 37,742 Mn), led by strong growth in packaging films (+17.9% YoY) and packaging (+15.0% YoY), with EBITDA margin expanding to 13.8% from 11.4% in Q2.
Normalized PAT surged 238.6% YoY to Rs. 1,112 Mn, with margin expanding to 2.9%; Q3 PAT was INR 111 crores, aided by positive currency movement in Nigeria.
Major investments announced: PET bottle and multi-layered plastic recycling in Noida (INR 317 crores), WPP bags plant in Mexico ($50M), and aseptic packaging expansion in India and Egypt.
Sustainability milestones include first Indian company to receive USFDA approval for recycled PCR content in food applications.
Capacity utilization improved across key plants: aseptic packaging at 104%, Nigeria at 90%, and Mexico at 98%.
Financial highlights
Q3 revenue: INR 3,774 crores (Rs. 37,742 Mn), up 12.8% YoY; Q3 sales volume: 157,036 MT (+6.3% YoY).
Q3 EBITDA margin: 13.8% (vs 11.4% in Q2); nine-month EBITDA margin: 12.6%.
Q3 PAT: INR 111 crores (Rs. 1,112 Mn), supported by positive currency impact from Nigeria.
Net debt at Rs. 61,507 Mn; net debt to EBITDA at 3.24x.
Q3 PBT before exceptional items: INR 147 crores.
Outlook and guidance
FY26 revenue expected to grow 12–15% over FY25, with EBITDA margin guidance of 14%.
Commercial operations for the new PET chips line in Egypt expected by end of Q4 FY25; aseptic packaging facility in Egypt to be commissioned by H2 FY26.
WPP plant in Mexico to begin operations in FY26, targeting the high-growth pet food packaging market.
Full-year FY26 EBITDA projected at INR 2,000 crores, with incremental volumes from new facilities.
Mexico and Nigeria plants expected to achieve 100% utilization in FY26; Poland targeted at 80%, Egypt at 90%+.
Latest events from Uflex
- 9MFY26 revenue up 0.8% YoY; Q3 down on weak volumes, but capex and sustainability to drive growth.500148
Q3 25/2616 Feb 2026 - Double-digit revenue and EBITDA growth, margin expansion, and strong outlook despite currency losses.500148
Q1 24/252 Feb 2026 - Strong revenue growth and global expansion offset by margin pressures from currency losses.500148
Q2 24/2513 Jan 2026 - Q1 FY26 revenue and profit rose, with expansion and regulatory shifts driving future growth.500148
Q1 25/2623 Nov 2025 - Turnaround year with strong profit, double-digit growth, and major global expansion.500148
Q4 24/2519 Nov 2025 - Q2 FY26 saw flat revenue, modest profit, and new capacity expansion amid regulatory headwinds.500148
Q2 25/2614 Nov 2025